Private investment house Ardian has acquired a majority stake in Masco Group, a global provider of products and services to the pharmaceutical and biotech industries, from RSBG SE, the holding subsidiary of RAG-Stiftung.
The Borella family and Masco Group’s current management team will reinvest alongside Ardian, while Luca Borella will continue to lead the company as CEO. Angelos Papadimitriou and Claudio Colombi will also invest in this transaction and will join the board of directors as Chairman and Director respectively.
Founded in 1912 and headquartered in Milan, Masco’s products and services include high-purity water systems, bioprocessing equipment, modular off-site fabricated facility solutions, process engineering, laboratory, validation and automation services. The company oversees seven facilities located across Europe, North America and Asia.
According to a press statement, Ardian will leverage its industry expertise in pharmaceutical and life sciences to support Masco in the next phase of growth, “driving a number of compelling organic initiatives, further international expansion, and completing acquisitions focused on strengthening the company’s technological capabilities while driving operational excellence”.
